LUMOS PHARMA, INC. Annual Depreciation, Depletion and Amortization in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Lumos Pharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- Lumos Pharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $2K, a 77.8% decline year-over-year.
- Lumos Pharma, Inc. annual Depreciation, Depletion and Amortization for 2023 was $44K, a 10.2% decline from 2022.
- Lumos Pharma, Inc. annual Depreciation, Depletion and Amortization for 2022 was $49K, a 77.4% decline from 2021.
- Lumos Pharma, Inc. annual Depreciation, Depletion and Amortization for 2021 was $217K, a 62.8% decline from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)